1
|
Reeder MJ, Zhang D, Aravamuthan SR, Warshaw EM, DeKoven JG, Silverberg JI, Adler BL, Atwater AR, Taylor JS, Houle MC, Belsito DV, Yu J, Botto N, Mowad CM, Dunnick CA, DeLeo VA, Pratt MD. More than just methylisothiazolinone: Retrospective analysis of patients with isothiazolinone allergy in North America, 2017-2020. J Am Acad Dermatol 2024; 90:319-327. [PMID: 37879460 DOI: 10.1016/j.jaad.2023.10.032] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2023] [Revised: 09/14/2023] [Accepted: 10/13/2023] [Indexed: 10/27/2023]
Abstract
BACKGROUND Isothiazolinones are a common cause of allergic contact dermatitis. OBJECTIVE To examine the prevalence of positive patch test reactions to isothiazolinones from 2017-2020 and characterize isothiazolinone-allergic (Is+) patients compared with isothiazolinone nonallergic (Is-) patients. METHODS Retrospective cross-sectional analysis of 9028 patients patch tested to methylchloroisothiazolinone (MCI)/methylisothiazolinone (MI) 0.02% aqueous, MI 0.2% aqueous, benzisothiazolinone (BIT) 0.1% petrolatum, and/or octylisothiazolinone (OIT) 0.025% petrolatum. Prevalence, reaction strength, concurrent reactions, clinical relevance, and source of allergens were tabulated. RESULTS In total, 21.9% (1976/9028) of patients had a positive reaction to 1 or more isothiazolinones. Positivity to MI was 14.4% (1296/9012), MCI/MI was 10.0% (903/9017), BIT was 8.6% (777/9018), and OIT was 05% (49/9028). Compared with Is-, Is+ patients were more likely to have occupational skin disease (16.5% vs 10.3%, P <.001), primary hand dermatitis (30.2% vs 19.7%, P <.001), and be >40 years (73.1% vs 61.9%, P <.001). Positive patch test reactions to >1 isothiazolinone occurred in 44.1% (871/1976) of Is+ patients. Testing solely to MCI/MI would miss 47.3% (611/1292) of MI and 60.1% (466/776) of BIT allergic reactions. LIMITATIONS Retrospective cross-sectional study design and lack of follow-up data. CONCLUSION Sensitization to isothiazolinones is high and concurrent sensitization to multiple isothiazolinone allergens is common.
Collapse
Affiliation(s)
- Margo J Reeder
- Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
| | - Donglin Zhang
- Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
| | - Srikanth R Aravamuthan
- Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
| | - Erin M Warshaw
- Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota; Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota
| | - Joel G DeKoven
- Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada
| | - Jonathan I Silverberg
- Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia
| | - Brandon L Adler
- Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California
| | - Amber R Atwater
- Department of Dermatology, Duke University Medical Center, Durham, North Carolina
| | - James S Taylor
- Department of Dermatology, Cleveland Clinic, Cleveland, Ohio
| | - Marie-Claude Houle
- Division of Dermatology, CHU de Quebec, Laval University, Quebec City, Canada
| | - Donald V Belsito
- Department of Dermatology, Columbia University Irving Medical School, New York, New York
| | - Jiade Yu
- Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
| | - Nina Botto
- Department of Dermatology, University of California, San Francisco, San Francisco, California
| | - Christen M Mowad
- Department of Dermatology, Geisinger Medical Center, Danville, Pennsylvania
| | - Cory A Dunnick
- Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Department of Dermatology, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado
| | - Vincent A DeLeo
- Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California
| | - Melanie D Pratt
- Division of Dermatology, University of Ottawa, Ottawa, Canada
| |
Collapse
|
2
|
Sullivan DA, da Costa AX, Del Duca E, Doll T, Grupcheva CN, Lazreg S, Liu SH, McGee SR, Murthy R, Narang P, Ng A, Nistico S, O'Dell L, Roos J, Shen J, Markoulli M. TFOS Lifestyle: Impact of cosmetics on the ocular surface. Ocul Surf 2023; 29:77-130. [PMID: 37061220 PMCID: PMC11246752 DOI: 10.1016/j.jtos.2023.04.005] [Citation(s) in RCA: 13] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2023] [Accepted: 04/06/2023] [Indexed: 04/17/2023]
Abstract
In this report the use of eye cosmetic products and procedures and how this represents a lifestyle challenge that may exacerbate or promote the development of ocular surface and adnexal disease is discussed. Multiple aspects of eye cosmetics are addressed, including their history and market value, psychological and social impacts, possible problems associated with cosmetic ingredients, products, and procedures, and regulations for eye cosmetic use. In addition, a systematic review that critically appraises randomized controlled trial evidence concerning the ocular effects of eyelash growth products is included. The findings of this systematic review highlight the evidence gaps and indicate future directions for research to focus on ocular surface outcomes associated with eyelash growth products.
Collapse
Affiliation(s)
| | | | - Ester Del Duca
- Icahn School of Medicine at Mount Sinai, New York City, NY, USA
| | | | | | - Sihem Lazreg
- Lazreg Cornea and Ocular Surface Center, Blida, Algeria
| | - Su-Hsun Liu
- University of Colorado, Anschutz Medical Campus, Aurora, CO, USA
| | | | | | | | - Alison Ng
- Centre for Ocular Research & Education, School of Optometry and Vision Science, University of Waterloo, Waterloo, Canada
| | - Steven Nistico
- Department of Dermatology, University Magna Graecia, Catanzaro, Italy
| | | | | | - Joanne Shen
- Department of Ophthalmology, Mayo Clinic in Arizona, Scottsdale, AZ, USA
| | - Maria Markoulli
- School of Optometry and Vision Science, UNSW Sydney, NSW, Australia
| |
Collapse
|
3
|
Contact Dermatitis Associated With Hair Care Products: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001-2016. Dermatitis 2021; 33:91-102. [PMID: 34149001 DOI: 10.1097/der.0000000000000760] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
BACKGROUND Hair care products (HCPs) may cause both allergic contact dermatitis (ACD) and irritant contact dermatitis (ICD). OBJECTIVES The aims of the study were to determine the prevalence of HCP-associated ICD/ACD and to characterize relevant allergens. METHODS This study is a retrospective analysis of North American Contact Dermatitis Group (NACDG) patch test data, 2001-2016. RESULTS Of 38,775 patients tested, 3481 (9.0%) had positive patch test reactions associated with HCPs. The HCP-positive patients were significantly more likely to be female (79.9% vs 66.0%) and/or have primary sites of dermatitis on the face (32.0% vs 27.8%) or scalp (15.4% vs 2.2%) compared with the HCP-negative patients (P < 0.0001). Of 4908 HCP-associated positive patch test reactions, 86.9% (n = 4263) were due to allergens on the NACDG screening series; p-phenylenediamine (35.8%), methylisothiazolinone (9.7%), methylchloroisothiazolinone/methylisothiazolinone (8.7%), and cocamidopropyl betaine (5.9%) were the most frequent. Most reactions (87.7%, 3736/4263) were currently clinically relevant. The most common job associated with 366 occupationally related NACDG HCP-associated allergens was hairdresser/cosmetologist (71.9%). Two hundred eighty-two patients (0.7%) had ICD associated with HCPs. Shampoo/conditioners were the most frequent source of NACDG HCP-associated reactions (47.3%) and HCP-associated ICD (45.0%). CONCLUSIONS Of the HCP-positive patients, 18.5% had HCP reactions to allergens not on the NACDG screening series, underscoring the importance of patch testing to expanded series in patients suspected of HCP allergy.
Collapse
|
4
|
Ahmed S, Sameen DE, Lu R, Li R, Dai J, Qin W, Liu Y. Research progress on antimicrobial materials for food packaging. Crit Rev Food Sci Nutr 2020; 62:3088-3102. [DOI: 10.1080/10408398.2020.1863327] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Saeed Ahmed
- College of Food Science, Sichuan Agricultural University, Ya’an, China
| | - Dur E. Sameen
- College of Food Science, Sichuan Agricultural University, Ya’an, China
| | - Rui Lu
- College of Food Science, Sichuan Agricultural University, Ya’an, China
| | - Rui Li
- College of Food Science, Sichuan Agricultural University, Ya’an, China
| | - Jianwu Dai
- College of Mechanical and Electrical Engineering, Sichuan Agricultural University, Ya’an, China
| | - Wen Qin
- College of Food Science, Sichuan Agricultural University, Ya’an, China
| | - Yaowen Liu
- College of Food Science, Sichuan Agricultural University, Ya’an, China
- California NanoSystems Institute, University of California, Los Angeles, CA, USA
| |
Collapse
|
5
|
Özkaya E, Kılıç Sayar S, Babuna Kobaner G, Pehlivan G. Methylchloroisothiazolinone/methylisothiazolinone and methylisothiazolinone contact allergy: A 24-year, single-center, retrospective cohort study from Turkey. Contact Dermatitis 2020; 84:24-33. [PMID: 32691417 DOI: 10.1111/cod.13656] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2020] [Revised: 06/25/2020] [Accepted: 07/08/2020] [Indexed: 11/29/2022]
Abstract
BACKGROUND Methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) and MI allergy caused a global epidemic during the period 2010 to 2015, reaching its peak in 2013/14. OBJECTIVE To investigate the characteristics of MCI/MI and MI allergy in Turkey over 24 years. METHODS A total of 2310 patients patch tested between 1996 and 2019 with MCI/MI 0.01% aq. or MCI/MI 0.02% aq., with or without MI 0.2% aq., were analyzed. RESULTS The overall prevalence of contact sensitization was 3.3% (n = 77) with a peak level of 16.4% in 2015. The prevalence gradually decreased thereafter, but was still high (6.5%) in 2019. Seventy-three patients had clinically relevant sensitizations. MI could detect clinically relevant sensitizations in all seven patients with a negative patch test reaction to MCI/MI 0.02%. Non-occupational allergic contact dermatitis (ACD) was most frequently seen, mainly in women, with hand/face eczema from rinse-off or leave-on cosmetics, such as wet wipes. Occupational ACD was mainly seen among men with airborne eczema from wall paints in house painters, or with hand eczema from hair gel/wax in men's barbers. CONCLUSIONS The prevalence of MCI/MI and MI sensitization in Turkey following the peak in 2015 is still high. This is probably due to the currently allowed level of 100 ppm for MI in rinse-off cosmetics. This needs to be urgently reduced.
Collapse
Affiliation(s)
- Esen Özkaya
- Department of Dermatology and Venereology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey
| | - Sıla Kılıç Sayar
- Department of Dermatology and Venereology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey
| | - Goncagül Babuna Kobaner
- Department of Dermatology and Venereology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey
| | - Gizem Pehlivan
- Department of Dermatology and Venereology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey
| |
Collapse
|
6
|
|
7
|
Qin O, Cheng Y, Hu W, Zhou H, Tan Y, Guo S, Jin X, Tao L, Du L, Wang J, Wang X, Zou Y, Maibach H. Patch test in Chinese in Shanghai with cosmetic allergy to cosmetic series and products. J Cosmet Dermatol 2019; 19:2086-2092. [PMID: 31820565 DOI: 10.1111/jocd.13249] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2019] [Revised: 11/05/2019] [Accepted: 11/21/2019] [Indexed: 11/30/2022]
Abstract
BACKGROUND There are increasing cosmetic adverse reactions in China, mostly cosmetic contact dermatitis, with the development of its cosmetics industry. AIMS To identify the allergens and cosmetics products responsible for cosmetic allergic contact dermatitis (CACD) in Shanghai. METHODS Five hundred and sixty patients, including 342 suspected CACD patients from dermatological clinic and 218 cosmetics consumers with an allergic history, were patch tested with a cosmetic series (C-1000 series). And 154 patients patched with possible culprit cosmetics. RESULTS Two hundred and forty-six subjects showed positive reaction to C-1000 series. Clinic patients had much higher positive rate than that of cosmetics consumers. Leading allergens were methylisothiazolinone (MI), methylisothiazolinone + methylchloro-isothiazolinone (MCI/MI), thimerosal, and the positive rates were significantly higher in patients than in cosmetic consumers (P < .001 for all). MCI/MI elicited positive patch test reactions in 73.5% of MI-positive patients. Of those patched with cosmetic products, 19 patients had 31 positive reactions, including 22 skin care products and 5 color decorating. CONCLUSIONS Preservatives, especially MI, MCI/MI, and thimerosal, were the most common cosmetic allergens, and skin care products occupied the most allergic reaction of CACD. Patch testing is highly recommended for suspected CACD patients. Future comparative investigation with large sample size should benefit cosmetovigilance surveillance.
Collapse
Affiliation(s)
- Ou Qin
- Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China
| | - Ying Cheng
- Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China
| | - Weiyi Hu
- Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China
| | - Hong Zhou
- Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China
| | - Yimei Tan
- Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China
| | - Shuting Guo
- Shanghai Food and Drug Administration, Shanghai, China
| | - Xin Jin
- Shanghai Food and Drug Administration, Shanghai, China
| | - Lin Tao
- Shanghai Center for Adverse Drug and Medical Device Reaction Monitoring, Shanghai, China
| | - Lei Du
- Shanghai Center for Adverse Drug and Medical Device Reaction Monitoring, Shanghai, China
| | - Jieheng Wang
- Shanghai Food and Drug Administration, Shanghai, China
| | - Xuemin Wang
- Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China
| | - Ying Zou
- Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China
| | - Howard Maibach
- Department of Dermatology, School of Medicine, University of California San Francisco, San Francisco, CA, USA
| |
Collapse
|
8
|
Schnuch A, Schubert S, Lessmann H, Geier J, Beiteke U, Dissemond J, Buhl T, Schäkel K, Pföhler C, Dietrich C, Worm M, Bauer A, Kreft B, Schliemann S, Brockow K, Becker D, Forchhammer S, Recke A, Witte J, Pfützner W, Coras‐Stepanek B, Skudlik C, Wagner N, Aberer W, Emmert S, Baron JM, Siedlecki K, Baur V, Schmieder A, Weisshaar E, Grunwald‐Delitz H, Trautmann A, Hofmeier KS, Szliska C, Weiß J, Effendy I, Jünger M, Brehler R, Rueff F, Werfel T, Dickel H, Rieker‐Schwienbacher J, Vieluf D, Stadler R, Simon D, Fartasch M, Micaletto S, Treudler R, Nestoris S, Mechtel D, Schröder‐Kraft C, Löffler H, Gina M, Koch A, Raap U, Grabbe J, Spring P, Prager W, Wilfinger D. The methylisothiazolinone epidemic goes along with changing patients' characteristics – After cosmetics, industrial applications are the focus. Contact Dermatitis 2019; 82:87-93. [DOI: 10.1111/cod.13414] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2019] [Revised: 10/07/2019] [Accepted: 10/07/2019] [Indexed: 12/11/2022]
Affiliation(s)
- Axel Schnuch
- Information Network of Department of Dermatology (IVDK)Institute at the University Medical Center Göttingen Göttingen Germany
| | - Steffen Schubert
- Information Network of Department of Dermatology (IVDK)Institute at the University Medical Center Göttingen Göttingen Germany
| | - Holger Lessmann
- Information Network of Department of Dermatology (IVDK)Institute at the University Medical Center Göttingen Göttingen Germany
| | - Johannes Geier
- Information Network of Department of Dermatology (IVDK)Institute at the University Medical Center Göttingen Göttingen Germany
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Burnett CL, Boyer I, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Gill LJ, Heldreth B. Amended Safety Assessment of Methylisothiazolinone as Used in Cosmetics. Int J Toxicol 2019; 38:70S-84S. [DOI: 10.1177/1091581819838792] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The Cosmetic Ingredient Review Expert Panel (Panel) reviewed the safety of methylisothiazolinone (MI), which functions as a preservative. The Panel reviewed relevant animal and human data provided in this safety assessment and in a previously published safety assessment of MI and concluded that MI is safe for use in rinse-off cosmetic products at concentrations up to 100 ppm and safe in leave-on cosmetic products when they are formulated to be nonsensitizing, which may be determined based on a quantitative risk assessment.
Collapse
Affiliation(s)
- Christina L. Burnett
- Cosmetic Ingredient Review Scientific Analyst/Writer, Cosmetic Ingredient Review, Washington, DC, USA
| | - Ivan Boyer
- Cosmetic Ingredient Review Former Toxicologist, Cosmetic Ingredient Review, Washington, DC, USA
| | - Wilma F. Bergfeld
- Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
| | - Donald V. Belsito
- Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
| | - Ronald A. Hill
- Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
| | - Curtis D. Klaassen
- Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
| | - Daniel C. Liebler
- Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
| | - James G. Marks
- Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
| | - Ronald C. Shank
- Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
| | - Thomas J. Slaga
- Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
| | - Paul W. Snyder
- Cosmetic Ingredient Review Expert Panel Member, Cosmetic Ingredient Review, Washington, DC, USA
| | - Lillian J. Gill
- Cosmetic Ingredient Review Former Director, Cosmetic Ingredient Review, Washington, DC, USA
| | - Bart Heldreth
- Cosmetic Ingredient Review Executive Director, Cosmetic Ingredient Review, Washington, DC, USA
| |
Collapse
|
10
|
Isothiazolinone in Residential Interior Wall Paint: A High-Performance Liquid Chromatographic-Mass Spectrometry Analysis. Dermatitis 2019; 29:332-338. [PMID: 30346324 DOI: 10.1097/der.0000000000000410] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND There is limited information regarding isothiazolinone content in residential wall paints in the United States. OBJECTIVE The aim of this study was to evaluate the prevalence of 5 isothiazolinones-methylisothiazolinone (MI), methylchloroisothiazolinone, benzisothiazolinone (BIT), butyl BIT, and octylisothiazolinone-in US residential wall paints. METHODS Forty-seven paints were obtained from retailers in Minneapolis/St Paul, Minnesota. Paint samples were assessed for the presence of the 5 isothiazolinones using high-performance liquid chromatographic-mass spectrometry. RESULTS At least 1 isothiazolinone was detected in all 47 paints. However, no paint contained butyl BIT, and only 1 paint had octylisothiazolinone. The MI and BIT were found in 96% and 94% of the paints, respectively. Methylisothiazolinone ranged in concentration from 17 to 358 ppm, whereas BIT varied from 29 to 1111 ppm. Methylchloroisothiazolinone was found solely in oil-based paints. Isothiazolinones were declared in 15% of Safety Data Sheets but did not correlate with high-performance liquid chromatographic-mass spectrometry. One "preservative-free" paint had BIT at 71.5 ppm. Paint sheen was not statistically associated with BIT or MI concentrations. Unpigmented paints and paints with volatile organic compound claims had significantly lower concentrations of MI, but not BIT. CONCLUSIONS All paints contained at least 1 isothiazolinone. Methylisothiazolinone and BIT were the most common. Safety Data Sheets are insufficient for ascertaining isothiazolinone content in US paints.
Collapse
|
11
|
Bouschon P, Waton J, Pereira B, Schmutz JL, Le Bouëdec MCF, D'Incan M. Methylisothiazolinone allergic contact dermatitis: Assessment of relapses in 139 patients after avoidance advice. Contact Dermatitis 2019; 80:304-310. [DOI: 10.1111/cod.13221] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2018] [Revised: 01/10/2019] [Accepted: 01/13/2019] [Indexed: 01/09/2023]
Affiliation(s)
- Pauline Bouschon
- Department of Dermatology, CHU; Université Clermont-Auvergne; Clermont-Ferrand France
| | - Julie Waton
- Department of Dermatology, CHU; Université de Lorraine; Nancy France
| | - Bruno Pereira
- Department of Biostatistics, CHU; Clermont-Ferrand France
| | - Jean-Luc Schmutz
- Department of Dermatology, CHU; Université de Lorraine; Nancy France
| | | | - Michel D'Incan
- Department of Dermatology, CHU; Université Clermont-Auvergne; Clermont-Ferrand France
| |
Collapse
|
12
|
Herman A, Aerts O, de Montjoye L, Tromme I, Goossens A, Baeck M. Isothiazolinone derivatives and allergic contact dermatitis: a review and update. J Eur Acad Dermatol Venereol 2018; 33:267-276. [PMID: 30284765 DOI: 10.1111/jdv.15267] [Citation(s) in RCA: 92] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2018] [Accepted: 08/20/2018] [Indexed: 01/12/2023]
Abstract
Allergic contact dermatitis (ACD) from isothiazolinones has frequently been described in the literature. Following an epidemic of sensitization to methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) in the 1980s, and more recently to MI, the Scientific Committee on Consumer Safety of the European Commission banned their use in leave-on products, while restricting that in rinse-off cosmetics. Despite a decreasing prevalence of ACD from MCI/MI and MI, cases caused by occupational exposure and non-cosmetic isothiazolinone sources are on the rise. Moreover, sensitization to newer and lesser known isothiazolinones has been reported. This paper reviews the epidemiology of contact allergy to different isothiazolinones, clinical presentation of isothiazolinone-induced ACD, most relevant sensitization sources and potential cross-reactions between isothiazolinone derivatives. It also provides an update on recent legislative measures.
Collapse
Affiliation(s)
- A Herman
- Department of Dermatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
| | - O Aerts
- Department of Dermatology, University Hospital Antwerp (UZA) and University of Antwerp (UA), Antwerp, Belgium
| | - L de Montjoye
- Department of Dermatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
| | - I Tromme
- Department of Dermatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
| | - A Goossens
- Department of Dermatology, University Hospital KU Leuven, Leuven, Belgium
| | - M Baeck
- Department of Dermatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
| |
Collapse
|
13
|
Assier H, Tetart F, Avenel-Audran M, Barbaud A, Ferrier-le Bouëdec MC, Giordano-Labadie F, Milpied B, Amsler E, Collet E, Girardin P, Soria A, Waton J, Truchetet F, Bourrain JL, Gener G, Bernier C, Raison-Peyron N. Is a specific eyelid patch test series useful? Results of a French prospective study. Contact Dermatitis 2018; 79:157-161. [PMID: 29882592 DOI: 10.1111/cod.13040] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2018] [Revised: 04/27/2018] [Accepted: 04/29/2018] [Indexed: 10/14/2022]
Abstract
BACKGROUND Eyelids are frequent sites of contact dermatitis. No prospective study focused on eyelid allergic contact dermatitis (EACD) has yet been published, and this topic has never been studied in French patients. OBJECTIVES To prospectively evaluate the usefulness of an eyelid series in French patients patch tested because of EACD, and to describe these patients. METHODS We prospectively analysed standardized data for all patients referred to our departments between September 2014 and August 2016 for patch testing for suspected EACD as the main reason. All patients were patch tested with an eyelid series, the European baseline series (EBS), the French additional series, and their personal products. Patch testing with additional series and repeated open application tests (ROATs) or open tests were performed if necessary. A standardized assessment of the relevance was used, and the analysis of the results was focused on patients having positive test results with a current certain relevance. RESULTS Two-hundred and sixty-four patients (238 women and 26 men) were included. Three-hundred and twenty-two tests gave positive results in 167 patients, 84 of whom had currently relevant reactions: 56 had currently relevant positive test reactions to the EBS, 16 had currently relevant positive test reactions to their personal products, 8 had currently relevant positive test reactions to the French additional series, and 4 had currently relevant positive test reactions to the eyelid series. Sixty-seven per cent of all relevant cases were related to cosmetic products. The most frequent allergens with current relevance were methylisothiazolinone (10.2%), fragrance mix I (3%), nickel (2.7%), hydroxyperoxides of linalool (2.7%) and limonene (2.3%), and Myroxylon pereirae (2.3%). Current atopic dermatitis was found in 9.5% of patients. The duration of dermatitis was shorter (23.2 vs 34.2 months; P = .035) in patients with currently relevant test reactions. The percentage of currently relevant tests remained the same when atopic patients or dermatitis localized only on the eyelids were taken into account. CONCLUSION In French patients, testing for EACD with the extended baseline series and personal products, also including ROATs and use tests, appears to be adequate, considering the currently relevant positive test reactions. The regular addition of an eyelid series does not seem to be necessary.
Collapse
Affiliation(s)
- Haudrey Assier
- Department of Dermatology, CHU Henri-Mondor, Créteil, France
| | | | | | - Annick Barbaud
- Department of Dermatology and Allergy, Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
| | | | | | | | - Emmanuelle Amsler
- Department of Dermatology and Allergy, Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
| | - Evelyne Collet
- Department of Dermatology, Hôpital le Bocage, Dijon, France
| | | | - Angèle Soria
- Department of Dermatology and Allergy, Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France
| | - Julie Waton
- Department of Dermatology, CHRU Nancy, Nancy, France
| | | | | | | | | | | | | |
Collapse
|
14
|
Ezendam J, Bokkers B, Bil W, Delmaar J. Skin sensitisation quantitative risk assessment (QRA) based on aggregate dermal exposure to methylisothiazolinone in personal care and household cleaning products. Food Chem Toxicol 2018; 112:242-250. [DOI: 10.1016/j.fct.2017.12.054] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2017] [Revised: 12/14/2017] [Accepted: 12/22/2017] [Indexed: 11/28/2022]
|
15
|
Contact Dermatitis Associated With Skin Cleansers: Retrospective Analysis of North American Contact Dermatitis Group Data 2000–2014. Dermatitis 2018; 29:32-42. [DOI: 10.1097/der.0000000000000330] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
16
|
Dao H, Lakhani P, Police A, Kallakunta V, Ajjarapu SS, Wu KW, Ponkshe P, Repka MA, Narasimha Murthy S. Microbial Stability of Pharmaceutical and Cosmetic Products. AAPS PharmSciTech 2018; 19:60-78. [PMID: 29019083 DOI: 10.1208/s12249-017-0875-1] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2017] [Accepted: 09/05/2017] [Indexed: 12/24/2022] Open
Abstract
This review gives a brief overview about microbial contamination in pharmaceutical products. We discuss the distribution and potential sources of microorganisms in different areas, ranging from manufacturing sites, pharmacy stores, hospitals, to the post-market phase. We also discuss the factors that affect microbial contamination in popular dosage forms (e.g., tablets, sterile products, cosmetics). When these products are contaminated, the microorganisms can cause changes. The effects range from mild changes (e.g., discoloration, texture alteration) to severe effects (e.g., changes in activities, toxicity). The most common method for countering microbial contamination is the use of preservatives. We review some frequently used preservatives, and we describe the mechanisms by which microorganisms develop resistance to these preservatives. Finally, because preservatives are inherently toxic, we review the efforts of researchers to utilize water activity and other non-preservative approaches to combat microbial contamination.
Collapse
|
17
|
Liao SL, Tseng YH, Chu CY. Contact allergy to methylisothiazolinone/methylchloroisothiazolinone: A retrospective case series in a referral center in northern Taiwan. DERMATOL SIN 2017. [DOI: 10.1016/j.dsi.2017.06.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
18
|
Pastor-Nieto MA, Alcántara-Nicolás F, Melgar-Molero V, Pérez-Mesonero R, Vergara-Sánchez A, Martín-Fuentes A, González-Muñoz P, de Eusebio-Murillo E. Conservantes en productos de higiene y cosméticos, medicamentos tópicos y productos de limpieza doméstica en España. ACTAS DERMO-SIFILIOGRAFICAS 2017; 108:758-770. [DOI: 10.1016/j.ad.2017.04.003] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2016] [Revised: 04/01/2017] [Accepted: 04/09/2017] [Indexed: 10/19/2022] Open
|
19
|
Preservatives in Personal Hygiene and Cosmetic Products, Topical Medications, and Household Cleaners in Spain. ACTAS DERMO-SIFILIOGRAFICAS 2017. [DOI: 10.1016/j.adengl.2017.07.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
20
|
Amsler E, Aerts O, Raison-Peyron N, Debons M, Milpied B, Giordano-Labadie F, Waton J, Ferrier-Le Bouëdec MC, Lartigau I, Pecquet C, Assier H, Avenel-Audran M, Bernier C, Castelain F, Collet E, Crépy MN, Genillier N, Girardin P, Pralong P, Tetart F, Vital-Durand D, Soria A, Barbaud A. Airborne allergic contact dermatitis caused by isothiazolinones in water-based paints: a retrospective study of 44 cases. Contact Dermatitis 2017; 77:163-170. [DOI: 10.1111/cod.12795] [Citation(s) in RCA: 47] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2016] [Revised: 02/12/2017] [Accepted: 02/13/2017] [Indexed: 11/30/2022]
Affiliation(s)
- Emmanuelle Amsler
- Dermatology and Allergology Department, Tenon Hospital (AP-HP); Sorbonne Universities, UPMC University Paris 06; 75020 Paris France
| | - Olivier Aerts
- Department of Dermatology; University Hospital Antwerp and University of Antwerp; Wilrijkstraat 10, 2650 Antwerp Belgium
| | | | | | - Brigitte Milpied
- Department of Dermatology; Saint André Hospital; 33000 Bordeaux France
| | | | - Julie Waton
- Dermatology and Allergy Department, Brabois Hospital; University Hospital of Nancy; 54500 Vandoeuvre les Nancy France
| | - Marie C. Ferrier-Le Bouëdec
- Department of Dermatology, CHU Clermont-Ferrand; University Clermont Auvergne; 63000 Clermont-Ferrand France
| | | | - Catherine Pecquet
- Dermatology and Allergology Department, Tenon Hospital (AP-HP); Sorbonne Universities, UPMC University Paris 06; 75020 Paris France
| | - Haudrey Assier
- Department of Dermatology; Henri Mondor Hospital; 94010 Créteil France
| | | | - Claire Bernier
- Department of Dermatology; Hôtel-Dieu Hospital; 44093 Nantes France
| | - Florence Castelain
- Department of Dermatology and Allergology, CHU Jean Minjoz; 25030 Besançon France
| | - Evelyne Collet
- Department of Dermatology; CHU-François Mitterand Hospital; 21000 Dijon France
| | | | | | - Pascal Girardin
- Department of Dermatology and Allergology, CHU Jean Minjoz; 25030 Besançon France
| | - Pauline Pralong
- Department of Dermatology, Allergology and Photobiology, CHU; 38700 Grenoble France
| | - Florence Tetart
- Department of Dermatology; Charles Nicolle Hospital; 76031 Rouen France
| | | | - Angele Soria
- Dermatology and Allergology Department, Tenon Hospital (AP-HP); Sorbonne Universities, UPMC University Paris 06; 75020 Paris France
| | - Annick Barbaud
- Dermatology and Allergology Department, Tenon Hospital (AP-HP); Sorbonne Universities, UPMC University Paris 06; 75020 Paris France
- Dermatology and Allergy Department, Brabois Hospital; University Hospital of Nancy; 54500 Vandoeuvre les Nancy France
| | | |
Collapse
|
21
|
Aerts O, Lambert J, Goossens A. Structures chimiques et allergies croisées entre isothiazolinones. REVUE FRANCAISE D ALLERGOLOGIE 2017. [DOI: 10.1016/j.reval.2017.02.013] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
22
|
|
23
|
Schwensen JF, Uter W, Bruze M, Svedman C, Goossens A, Wilkinson M, Giménez Arnau A, Gonçalo M, Andersen KE, Paulsen E, Agner T, Foti C, Aalto-Korte K, McFadden J, White I, Johansen JD. The epidemic of methylisothiazolinone: a European prospective study. Contact Dermatitis 2016; 76:272-279. [DOI: 10.1111/cod.12733] [Citation(s) in RCA: 70] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2016] [Accepted: 10/25/2016] [Indexed: 11/29/2022]
Affiliation(s)
- Jakob F. Schwensen
- Department of Dermato-Allergology, National Allergy Research Centre, Gentofte Hospital; University of Copenhagen; 2900 Hellerup Denmark
| | - Wolfgang Uter
- Department of Medical Informatics, Biometry and Epidemiology; University of Erlangen/Nürnberg; 91054 Erlangen Germany
| | - Magnus Bruze
- Department of Occupational and Environmental Dermatology; Lund University, Skåne University Hospital; 205 02 Malmö Sweden
| | - Cecilia Svedman
- Department of Occupational and Environmental Dermatology; Lund University, Skåne University Hospital; 205 02 Malmö Sweden
| | - An Goossens
- Contact Allergy Unit, Department of Dermatology; University Hospital KU Leuven; 3000 Leuven Belgium
| | - Mark Wilkinson
- Department of dermatology, Leeds Teaching Hospitals NHS Trust; Leeds LS7 4SA UK
| | - Ana Giménez Arnau
- Department of Dermatology, Hospital del Mar; Universitat Autònoma de Barcelona; 08003 Barcelona Spain
| | - Margarida Gonçalo
- Department of Dermatology; University Hospital and Faculty of Medicine, University of Coimbra; 3000-075 Coimbra Portugal
| | - Klaus E. Andersen
- Department of Dermatology and Allergy Centre; Odense University Hospital, University of Southern Denmark; 5000 Odense Denmark
- Centre for Innovative Medical Technology, Institute of Clinical Research; Odense University Hospital, University of Southern Denmark; 5000 Odense Denmark
| | - Evy Paulsen
- Department of Dermatology and Allergy Centre; Odense University Hospital, University of Southern Denmark; 5000 Odense Denmark
| | - Tove Agner
- Department of Dermatology; University of Copenhagen, Bispebjerg Hospital; 2400 Copenhagen Denmark
| | - Caterina Foti
- Unit of Dermatology, Department of Biomedical Science and Human Oncology; University of Bari; 70124 Bari Italy
| | - Kristiina Aalto-Korte
- Occupational Medicine; Finnish Institute of Occupational Health; 00250 Helsinki Finland
| | - John McFadden
- St John's Institute of Dermatology; St Thomas' Hospital; London SE1 7EH UK
| | - Ian White
- St John's Institute of Dermatology; St Thomas' Hospital; London SE1 7EH UK
| | - Jeanne D. Johansen
- Department of Dermato-Allergology, National Allergy Research Centre, Gentofte Hospital; University of Copenhagen; 2900 Hellerup Denmark
| | | |
Collapse
|
24
|
Schwensen J, Menné Bonefeld C, Zachariae C, Agerbeck C, Petersen T, Geisler C, Bollmann U, Bester K, Johansen J. Cross‐reactivity between methylisothiazolinone, octylisothiazolinone and benzisothiazolinone using a modified local lymph node assay. Br J Dermatol 2016; 176:176-183. [DOI: 10.1111/bjd.14825] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/01/2016] [Indexed: 10/21/2022]
Affiliation(s)
- J.F. Schwensen
- National Allergy Research Centre Department of Dermato‐Allergology Copenhagen University Hospital Gentofte Kildegårds Allé 2900 Hellerup Denmark
| | - C. Menné Bonefeld
- Department of Immunology and Microbiology Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark
| | - C. Zachariae
- Department of Dermato‐Allergology Copenhagen University Hospital Gentofte Kildegårds Allé 2900 Hellerup Denmark
| | - C. Agerbeck
- Department of Immunology and Microbiology Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark
| | - T.H. Petersen
- Department of Immunology and Microbiology Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark
| | - C. Geisler
- Department of Immunology and Microbiology Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark
| | - U.E. Bollmann
- Department of Environmental Science Aarhus University Frederiksborgvej 399 4000 Roskilde Denmark
| | - K. Bester
- Department of Environmental Science Aarhus University Frederiksborgvej 399 4000 Roskilde Denmark
| | - J.D. Johansen
- National Allergy Research Centre Department of Dermato‐Allergology Copenhagen University Hospital Gentofte Kildegårds Allé 2900 Hellerup Denmark
| |
Collapse
|
25
|
|
26
|
Microbiologically Contaminated and Over-Preserved Cosmetic Products According Rapex 2008–2014. COSMETICS 2016. [DOI: 10.3390/cosmetics3010003] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
|
27
|
Schwensen JF, Bregnbak D, Johansen JD. Recent trends in epidemiology, sensitization and legal requirements of selected relevant contact allergens. Expert Rev Clin Immunol 2015; 12:289-300. [DOI: 10.1586/1744666x.2016.1120159] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Jakob F. Schwensen
- National Allergy Research Centre, Department of Dermato-Allergology, Gentofte University Hospital, Hellerup, Denmark
| | - David Bregnbak
- National Allergy Research Centre, Department of Dermato-Allergology, Gentofte University Hospital, Hellerup, Denmark
| | - Jeanne Duus Johansen
- National Allergy Research Centre, Department of Dermato-Allergology, Gentofte University Hospital, Hellerup, Denmark
| |
Collapse
|
28
|
Abstract
Skin sensitization associated with allergic contact dermatitis is a common health problem and is an important consideration for toxicologists in safety assessment. Historically, in vivo predictive tests have been used with good success to identify substances that have the potential to induce skin sensitization, and these tests formed the basis of safety evaluation. These original tests are now being replaced gradually either by in vitro assays or by further refinements of in vivo methods such as the local lymph node assay. Human data have also been available to inform classification decisions for some substances and have been used by risk managers to introduce measures for exposure reduction. However, humans encounter hazards in the context of exposure rather than in the form of intrinsic hazards per se, and so in this article, we have examined critically the extent to which human data have been used to refine classification decisions and safety evaluations. We have also evaluated information on the burden of human allergic skin disease and used this to address the question of whether, and to what extent, the identification and evaluation of skin sensitization hazards has led to an improvement of public and/or occupational health.
Collapse
Affiliation(s)
| | - IR White
- Department of Cutaneous Allergy, St John’s Institute of Dermatology, St Thomas’ Hospital, London, UK
| | - JP McFadden
- Department of Cutaneous Allergy, St John’s Institute of Dermatology, St Thomas’ Hospital, London, UK
| | - I Kimber
- Faculty of Life Sciences, The University of Manchester, Manchester, UK
| |
Collapse
|
29
|
Badaoui A, Bayrou O, Fite C, Frances C, Soria A, Pecquet C. Allergic contact dermatitis caused by methylisothiazolinone in hair gel. Contact Dermatitis 2015; 73:364-6. [DOI: 10.1111/cod.12467] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2015] [Revised: 07/27/2015] [Accepted: 07/27/2015] [Indexed: 11/25/2022]
Affiliation(s)
- Antoine Badaoui
- Dermatologie-Allergologie; Hôpital Tenon, HUEP, APHP; 75020 Paris France
| | - Olivier Bayrou
- Dermatologie-Allergologie; Hôpital Tenon, HUEP, APHP; 75020 Paris France
| | | | - Camille Frances
- Dermatologie-Allergologie; Hôpital Tenon, HUEP, APHP; 75020 Paris France
| | - Angele Soria
- Dermatologie-Allergologie; Hôpital Tenon, HUEP, APHP; 75020 Paris France
- Unité Mixte de Recherche de Santé (UMR S) CR7, Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), UPMC Université Paris 06, Sorbonne Universités; F-75013 Paris France
- Institut National de Santé et de Recherche Médicale (INSERM) U1135, Cimi-Paris; F-75013 Paris France
| | - Catherine Pecquet
- Dermatologie-Allergologie; Hôpital Tenon, HUEP, APHP; 75020 Paris France
| |
Collapse
|
30
|
Abstract
Dermatoses have been better characterized as hypochromic vitiligo in subjects with dark skin or the acquired racquet nails associated with hyperparathyroidism. The innate immunity has a central role in the new classification of auto inflammatory diseases, neutrophilic dermatoses, neutrophilic urticaria or pseudo-neutrophilic urticaria. Comorbidities have been studied e.g. cardiovascular co morbidities for psoriasis, IBD associated with hidradenitis suppurativa or neurological disorders associated with pemphigoid. Bullous pemphigoid could be renamed as cutaneous pemphigoid, it can be induced by drugs especially gliptins. Genetic predispositions are analyzed in auto inflammatory diseases, psoriasis (HLA), drug eruptions (HLA or cytokines). Telaprevir often induces rashes, which can be severe but other treatments against hepatitis C as interferon can also induce debilitating rashes, some eligible for drug tolerance induction. European guidelines for the definition, classification, diagnosis of chronic spontaneous urticaria have been published. Severe cutaneous adverse drug reactions may be associated with severe systemic symptoms such as organ involvement in AGEP or the occurrence of a shock in DRESS. Allover Europe, there is now an epidemic of contact allergies to methylisothiazolinone (MIT), contained in cosmetics, wet wipes but also in paints. MIT should be tested at 2.000 ppm in water, included in the standard series for patch tests. Its role has to be evoked in any case localized on the face or hand, airborne or generalized eczema. Among infectious diseases, skin manifestations due to Parvovirus have been specified, a febrile rash can be related to dengue infection or to Zika virus.
Collapse
Affiliation(s)
- A Barbaud
- Département de dermatologie et allergologie, bâtiment des spécialités médicales, hôpitaux de Brabois, centre hospitalo-universitaire de Nancy, 54500 Vandœuvre-les-Nancy, France.
| |
Collapse
|
31
|
Schwensen JF, White IR, Thyssen JP, Menné T, Johansen JD. Failures in risk assessment and risk management for cosmetic preservatives in Europe and the impact on public health. Contact Dermatitis 2015; 73:133-41. [DOI: 10.1111/cod.12446] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2015] [Revised: 05/29/2015] [Accepted: 05/30/2015] [Indexed: 11/29/2022]
Affiliation(s)
- Jakob F. Schwensen
- Department of Dermato-Allergology; National Allergy Research Centre, Copenhagen University Hospital Gentofte; 2900 Hellerup Denmark
| | - Ian R. White
- St John's Institute of Dermatology, St Thomas' Hospital; London SE1 7EH UK
| | - Jacob P. Thyssen
- Department of Dermato-Allergology; Copenhagen University Hospital Gentofte; 2900 Hellerup Denmark
| | - Torkil Menné
- Department of Dermato-Allergology; National Allergy Research Centre, Copenhagen University Hospital Gentofte; 2900 Hellerup Denmark
| | - Jeanne D. Johansen
- Department of Dermato-Allergology; National Allergy Research Centre, Copenhagen University Hospital Gentofte; 2900 Hellerup Denmark
| |
Collapse
|
32
|
Yazar K, Lundov M, Faurschou A, Matura M, Boman A, Johansen J, Lidén C. Methylisothiazolinone in rinse-off products causes allergic contact dermatitis: a repeated open-application study. Br J Dermatol 2015; 173:115-22. [DOI: 10.1111/bjd.13751] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/16/2015] [Indexed: 11/29/2022]
Affiliation(s)
- K. Yazar
- Institute of Environmental Medicine; Karolinska Institutet; Box 210 SE-17177 Stockholm Sweden
| | - M.D. Lundov
- Department of Dermato-Allergology; National Allergy Research Centre; Copenhagen University Hospital Gentofte; Hellerup Denmark
| | - A. Faurschou
- Department of Dermato-Allergology; National Allergy Research Centre; Copenhagen University Hospital Gentofte; Hellerup Denmark
| | - M. Matura
- Centre for Occupational and Environmental Medicine; Stockholm County Council; Stockholm Sweden
| | - A. Boman
- Institute of Environmental Medicine; Karolinska Institutet; Box 210 SE-17177 Stockholm Sweden
| | - J.D. Johansen
- Department of Dermato-Allergology; National Allergy Research Centre; Copenhagen University Hospital Gentofte; Hellerup Denmark
| | - C. Lidén
- Institute of Environmental Medicine; Karolinska Institutet; Box 210 SE-17177 Stockholm Sweden
| |
Collapse
|
33
|
|
34
|
Schwensen JF, Lundov MD, Bossi R, Banerjee P, Gimenez-Arnau E, Lepoittevin JP, Lidén C, Uter W, Yazar K, White IR, Johansen JD. Methylisothiazolinone and benzisothiazolinone are widely used in paint: a multicentre study of paints from five European countries. Contact Dermatitis 2014; 72:127-38. [DOI: 10.1111/cod.12322] [Citation(s) in RCA: 75] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2014] [Revised: 10/29/2014] [Accepted: 10/30/2014] [Indexed: 11/26/2022]
Affiliation(s)
- Jakob F. Schwensen
- Department of Dermato-Allergology; National Allergy Research Centre, Gentofte University Hospital; 2820, Ledrebrog Allé 40 Gentofte Denmark
| | - Michael D. Lundov
- Department of Dermato-Allergology; National Allergy Research Centre, Gentofte University Hospital; 2820, Ledrebrog Allé 40 Gentofte Denmark
| | - Rossana Bossi
- Department of Environmental Science; Aarhus University; Roskilde 4000, Frederiksborgvej 399 Aarhus Denmark
| | - Piu Banerjee
- St John's Institute of Dermatology, St Thomas' Hospital; London SE1 7EH Lambeth Palace Road UK
| | - Elena Gimenez-Arnau
- Laboratoire de Dermatochimie; CNRS and University of Strasbourg; 67091 Strasbourg France
| | | | - Carola Lidén
- Institute of Environmental Medicine, Karolinska Institutet; SE-171 77 Stockholm Sweden
| | - Wolfgang Uter
- Department of Medical Informatics, Biometry and Epidemiology; Friedrich-Alexander University; 91054 Erlangen, Waldstr. 4-6 Erlangen Germany
| | - Kerem Yazar
- Institute of Environmental Medicine, Karolinska Institutet; SE-171 77 Stockholm Sweden
| | - Ian R. White
- St John's Institute of Dermatology, St Thomas' Hospital; London SE1 7EH Lambeth Palace Road UK
| | - Jeanne D. Johansen
- Department of Dermato-Allergology; National Allergy Research Centre, Gentofte University Hospital; 2820, Ledrebrog Allé 40 Gentofte Denmark
| |
Collapse
|
35
|
Schwensen JF, Menné T, Andersen KE, Sommerlund M, Johansen JD. Occupations at risk of developing contact allergy to isothiazolinones in Danish contact dermatitis patients: results from a Danish multicentre study (2009-2012). Contact Dermatitis 2014; 71:295-302. [DOI: 10.1111/cod.12286] [Citation(s) in RCA: 46] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2014] [Revised: 06/03/2014] [Accepted: 06/17/2014] [Indexed: 11/26/2022]
Affiliation(s)
- Jakob F. Schwensen
- Department of Dermato-Allergology; National Allergy Research Centre, Copenhagen University Hospital Gentofte; 2900 Hellerup Denmark
| | - Torkil Menné
- Department of Dermato-Allergology; National Allergy Research Centre, Copenhagen University Hospital Gentofte; 2900 Hellerup Denmark
| | - Klaus E. Andersen
- Department of Dermatology and Allergy Centre; Odense University Hospital; 5000 Odense C Denmark
| | - Mette Sommerlund
- Department of Dermatology; Aarhus University Hospital; 8000 Aarhus Denmark
| | - Jeanne D. Johansen
- Department of Dermato-Allergology; National Allergy Research Centre, Copenhagen University Hospital Gentofte; 2900 Hellerup Denmark
| |
Collapse
|